Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

349
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
349
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

1.3K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Guidelines in Action: Blood Pressure Management in the Setting of an Acute Intracerebral Hemorrhage.

Stroke·2026
Same author

Transcranial Doppler After Successful Endovascular Revascularization and Hospitalization Outcomes.

Stroke (Hoboken, N.J.)·2026
Same author

Outcomes of a blood pressure control protocol for intracerebral hemorrhage in the emergency department.

The American journal of emergency medicine·2025
Same author

Hematoma expansion in intracerebral hemorrhage retrospective chart review: Who are the super-expanders?

Clinical neurology and neurosurgery·2025
Same author

Electromagnetic Stimulation to Reduce Disability After Ischemic Stroke: The EMAGINE Randomized Clinical Trial.

JAMA network open·2025
Same author

Time to Acute Treatment in Intracerebral Hemorrhage Lags Significantly Behind Ischemic Stroke: A Multicenter, Observational Retrospective Study.

Stroke·2025
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Related Experiment Video

Updated: Mar 2, 2026

Bilateral Common Carotid Artery Occlusion as an Adequate Preconditioning Stimulus to Induce Early Ischemic Tolerance to Focal Cerebral Ischemia
07:46

Bilateral Common Carotid Artery Occlusion as an Adequate Preconditioning Stimulus to Induce Early Ischemic Tolerance to Focal Cerebral Ischemia

Published on: May 9, 2013

30.3K

Ischemic Preconditioning in the Intensive Care Unit.

Maranatha Ayodele1, Sebastian Koch2

  • 1Department of Neurology, University of Miami, Miller School of Medicine, 1120 NW 14th Street, CRB 1353, Miami, FL, 33136, USA. mayodele@med.miami.edu.

Current Treatment Options in Neurology
|May 10, 2017
PubMed
Summary
This summary is machine-generated.

Ischemic preconditioning uses controlled stress to activate survival mechanisms, potentially protecting organs. However, its clinical effectiveness for neurological diseases and other conditions remains unproven due to gaps in understanding.

Keywords:
Ischemic preconditioning (IPC)NeuroprotectionPerconditioningPostconditioningRemote ischemic perconditioning (rPerC)Remote ischemic preconditioning (RIPC)

More Related Videos

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
07:52

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

12.7K
Use of a Hanging Weight System for Coronary Artery Occlusion in Mice
08:30

Use of a Hanging Weight System for Coronary Artery Occlusion in Mice

Published on: April 19, 2011

22.1K

Related Experiment Videos

Last Updated: Mar 2, 2026

Bilateral Common Carotid Artery Occlusion as an Adequate Preconditioning Stimulus to Induce Early Ischemic Tolerance to Focal Cerebral Ischemia
07:46

Bilateral Common Carotid Artery Occlusion as an Adequate Preconditioning Stimulus to Induce Early Ischemic Tolerance to Focal Cerebral Ischemia

Published on: May 9, 2013

30.3K
Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
07:52

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

12.7K
Use of a Hanging Weight System for Coronary Artery Occlusion in Mice
08:30

Use of a Hanging Weight System for Coronary Artery Occlusion in Mice

Published on: April 19, 2011

22.1K

Area of Science:

  • Physiology
  • Molecular Biology
  • Evolutionary Biology

Background:

  • Preconditioning involves exposing organisms to sub-lethal stressors to enhance resilience against lethal doses.
  • This process leverages evolved endogenous survival mechanisms to cope with environmental challenges.
  • Mechanisms include gene expression changes, protein synthesis, and post-translational modifications.

Purpose of the Study:

  • To review ischemic preconditioning (IP) mechanisms and its potential for treating acute neurological diseases.
  • To examine the clinical translation of IP and its efficacy in various settings.
  • To identify challenges and knowledge gaps hindering the optimal application of IP.

Main Methods:

  • Literature review of pre-clinical and clinical studies on ischemic preconditioning.
  • Analysis of biological mechanisms underlying preconditioning responses.
  • Evaluation of recent clinical trial outcomes for IP's therapeutic potential.

Main Results:

  • Pre-clinical research strongly supports IP as a protective phenomenon.
  • Clinical trials show mixed results: protective effects in acute kidney injury, but no benefit in combined cardio-, neuro-, and renoprotection trials.
  • Clinical utility of IP is currently unproven, with diverging conclusions across studies.

Conclusions:

  • Understanding the complex mechanisms of IP is crucial for its clinical application.
  • Further research is needed to overcome challenges and optimize the harnessing of IP's protective potential.
  • Bridging the gap between pre-clinical promise and clinical reality is essential for realizing IP's therapeutic benefits.